Refine by
Infection Medical Articles & Analysis
33 news found
Examples of minor infections listed include impetigo, scarlet fever, and strep throat. Some of the serious infections listed by the CDC include cellulitis, necrotizing fasciitis, and streptococcal toxic shock syndrome. ...
International Infection Prevention Week (IIPW) has been championed by the Association for Professionals in Infection Control and Epidemiology since 1986. ...
Infection: Many patients self-administer medication via injection, so it’s not just medical professionals who are at the risk of operator error with injections. ...
The rationale for this program is based in part on published clinical evidence from Seres’ collaborators at Memorial Sloan Kettering Cancer Center showing that allogeneic HSCT patients with decreased diversity of commensal microbes are significantly more likely to die due to infection and/or lethal GvHD. SER-155 was developed using Seres’ reverse translational ...
“These results suggest that our investigational microbiome therapeutic, SER-109, is a potentially fast-acting intervention that can provide durable relief from recurrent C. difficile infections when administered to vulnerable patients,” said Matthew Henn, Ph.D., Chief Scientific Officer at Seres. ...
“Microbiome-based therapeutics have the potential to protect medically compromised transplant patients from life-threatening infections and GvHD as they start on their road to recovery,” said Matthew Henn, PhD, Chief Scientific Officer at Seres and co-author. ...
Main disposable medical supplies include: Masks, Gloves, and Clothing Surgical and Dental Supplies Thermometers, Test supplies, and Syringes Specimen Collection and COVID-19 test kits Consequently, the market for disposable medical supplies is expected to grow significantly in 2022, and an additional 15% in the following years, as there is no production ...
SER-109 is an investigational oral microbiome therapeutic for the prevention of recurrentC. difficile infection (rCDI). With an oral and poster presentation, Seres will present data on how SER-109 restores the functionality of the microbiome in a rapid and durable manner, which further supports the potential of microbiome therapeutics. ...
SER-155 is an investigational oral, rationally designed, cultivated microbiome therapeutic designed to reduce the incidence of gastrointestinal infections, bloodstream infections, and GvHD in patients receiving allo-HSCT. ...
Food and Drug Administration (FDA) for the treatment of hantavirus infections. These RNA viruses may lead to serious diseases in humans with a high risk of fatality and have been classified by the CDC as a potential bioterrorism ...
The conference will examine new product developments, evolving global drivers, market trends and key industry sustainability initiatives over three days. “After a year where medical and infection prevention nonwoven-based product have more than ever demonstrated their essential character, it is quite natural that, again in this edition of OUTLOOK™, ...
ByEDANA
"Our goal is to decrease the usage of antibiotic therapy by 50% for the treatment of middle ear infections," said Caitlin Cameron, CEO OtoNexus Medical Technologies. We are delighted that Keiretsu Forum investors recognize our unique technology's value to provide the critical information physicians need to prescribe antibiotics for middle ear ...
This often leads to deadly secondary infections that can be multidrug resistant, and other complications. Dr. Michael Niederman, a leading expert in respiratory infections and a member of N8 Medical’s Scientific Advisory Board stated “Anything that can significantly reduce the presence of pathogens on the surface of an endotracheal ...
Infection control procedures including work practices, protocols and controls, environmental hygiene, air filtration and appropriate use of Personal Protective Equipment (PPE) are all necessary to prevent infections from spreading during healthcare service delivery. ...
N8 Medical, LLC (N8 Medical) today announced that the National Heart Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) indicated its intent to fund N8 Medical’s STTR Phase I grant application for the development of a resorbable envelope to prevent surgical site infections associated with pacemaker ...
Silver Bullet Therapeutics, Inc., a privately held medical device company that has developed an antimicrobial technology for implantable medical devices such as orthopedic bone screws, reported today the results of a study testing the “Time Kill” and “Adherence” effectiveness of its CE-marked OrthoFuzIon® Antimicrobial Bone Screw ...
“Our strategy is validated daily by either a news story of a medical device related surgical site infection, or the fact that a few of the large medical device companies are realizing that antimicrobial devices advance the practice of medicine, and set the stage for the next evolution of medical devices.” Statistics ...
Thus many patients require temporary infection-prone catheters with high mortality risk for many months while waiting for a functional fistula to develop. ...
“We take a lot of pride in not only our medical solutions, but also the breadth of our growing IP portfolio,” stated Paul Chirico, President and CEO of Silver Bullet Therapeutics. ...
These may include allergic reactions, lung infections, and infections in other organs. Aspergillosis is the name of infections caused by Aspergillus. ...